ERBB4 contributes to parathyroid cell dysfunction and progression of secondary hyperparathyroidism
Year: 2026
Type: article
Abstract: Secondary hyperparathyroidism (SHPT) is a frequent complication of chronic kidney disease (CKD), manifested by parathyroid hyperplasia and excessive parathyroid hormone (PTH) secretion. However, the regulatory mechanisms governing SHPT progression remain incompletely understood. To explore the molecular mechanisms underlying CKD-associated SHPT, we generated single-nucleus RNA-seq (snRNA-seq) profiles of parathyroid tissues from SHPT patients and control subjects to establish the transcriptional landscape comparing human normal and SHPT parathyroid glands. Pseudotime trajectory analysis revealed progressive enrichment of the ERBB signaling pathway along trajectories leading toward terminal cell states during parathyroid cell differentiation. Multiple RNA-seq datasets, including bulk transcriptomic data and publicly available transcriptomic data, were integrated to facilitate candidate gene screening. Integrated transcriptomic analyses identified ERBB4 as a markedly upregulated gene in parathyroid tissues from patients with SHPT, with particularly high expression in oxyphil cells. Subsequent analyses of snRNA-seq data confirmed robust activation of ERBB signaling in SHPT parathyroid tissues. Immunohistochemistry (IHC) further confirmed elevated ERBB4 protein levels in parathyroid tissues from uremic patients with SHPT. In vitro experiments using SHPT patient-derived primary parathyroid cells demonstrated that inhibition of ERBB4 or ERBB signaling suppressed parathyroid cell proliferation and reduced PTH secretion. Collectively, this study generates high-resolution transcriptomic profiles of human SHPT parathyroid tissues, delineates key cellular pathological features at single-nucleus resolution, and identifies ERBB4 as a potential contributor to parathyroid gland hyperfunction in CKD-related SHPT.
Authors: Lulin Ji, Zhongliang Hu
Institution: Central South University
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7236273541
